Docoh
Loading...

ACIU AC Immune

Filed: 7 Oct 21, 7:27am

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16
OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of October, 2021

 

 

Commission File Number: 001-37891

 

AC IMMUNE SA

(Exact name of registrant as specified in its charter)

 

EPFL Innovation Park

Building B

1015 Lausanne, Switzerland

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F

 Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

 

Yes ☐ No

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

 

Yes ☐ No

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 AC IMMUNE SA 
   
   
  By:/s/ Andrea Pfeifer 
   Name:Andrea Pfeifer 
   Title:Chief Executive Officer 
      
      
  By:/s/ Joerg Hornstein 
   Name:Joerg Hornstein 
   Title:Chief Financial Officer 

Date: October 7, 2021

 

 

 

EXHIBIT INDEX

 

Exhibit

Number

Description
99.1Invitation to the Extraordinary General Meeting
99.22021 Extraordinary General Meeting Proxy Card